🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Positive #data from a peer-reviewed study evaluating the in vitro efficacy of FLU-v, IMUTEX Ltd broad spectrum #influenza #vaccine candidate, has been published in the scientific journal @Vaccines | You. Learn more: londonstockexchange.com/news-article/O… #HVO #Imutex #Flu #ORPH

Our new investors section will be going live alongside our name change launch, which is expected to take place on 26 October 2022. Stay tuned...👀 and don't forget to follow hVIVO for updates #WatchThisSpace #StayTuned #Rebrand #HVO #hVIVO #ORPH

We announced that we will be changing our name from Open Orphan to #hVIVO on 26 Oct 2022. Our ticker will be changing from #ORPH to #HVO. Watch below to see reasons why we decided to make this strategic business decision... Follow hVIVO to keep up to date!

We will be attending next week's World Vaccine Congress in #Barcelona. Stop by stand #67 to learn more about our challenge models, lab services & Vaccine Studies. Our #CSO will be presenting during the event & look forward to seeing our industry colleagues #WVC2022 #WVCEurope

As part of our company name change to hVIVO, our social media will be moving across to the hVIVO socials. Make sure you follow #hVIVO to keep up to date with company newsflow. See you there 👋! The name change countdown is on...⏲️ #HVO

Make sure you follow @hvivo_uk to keep up to date with all company news following our name change on 26 Oct 2022.

Yesterday was a great day at the World Vaccine Congress 2022 #Europe event, held in the beautiful city of #Barcelona. Our #CFO presented "Utilising human challenge models to advance vaccine development" We are located at stand 67, come and join us! 👋 #hVIVO #HVO

Follow hVIVO & keep up to date with company & industry news...#HVO

Stephen Pinkerton has been appointed as #CFO and Exec Director of #ORPH. Wealth of experience: ☑️ 25 years in Senior Financial Roles ☑️ Served as Commercial Financial Director hVIVO since 2017 driving initiatives to improve profitability londonstockexchange.com/news-article/O… #HVO

Following this mornings announcement on Stephen Pinkerton's appointment as #CFO & Executive Director for the group, he caught up with @VoxPodcast to discuss his experience & how this change aligns with the company's growth Tune in👂 voxmarkets.co.uk/articles/steph… #HVO

Yesterday's announcement on the appointment of Stephen Pinkerton as #CFO and Executive Director, featured in City A.M.. Read full #article below: cityam.com/open-orphan-an… ✍️Jack Mendel #HVO #hVIVO #leadership Reminder: Follow hVIVO for future company updates

We're holding a Capital Markets Day on 2 Nov 2022. 🧑Chaired by our #CEO 🔬 Insights into the business 📈 Human challenge trials & the growing market 🗣️ Guest speakers, including Peter Openshaw ❓ Q&A with #ORPH management londonstockexchange.com/news-article/O… #HVO

Reminder to follow hVIVO to keep up to date with company & industry news…

Last week we announced our upcoming Capital Markets Day on Wednesday 2 November 2022 at 9.30 am - 12.00 pm (GMT). Register below if you would like to attend virtually ⏬ stream.brrmedia.co.uk/broadcast/634f… #HVO #CapitalMarketsDay #ORPH

Further to our recent announcement, #ORPH's name change to hVIVO plc has now been completed and is expected to take effect on LSEG AIM & Euronext Dublin from 8.00 am tomorrow. Learn more: londonstockexchange.com/news-article/O… Follow us on hVIVO to keep up to date! #HVO

Today we officially change our name to hVIVO on LSEG AIM and Euronext Dublin📣 Find all the latest news & investor information here: hvivo.com 👉Don’t forget to start following hVIVO. 📈 Our new ticker is #HVO

Our #CEO caught up with @BRR_Media to discuss the name change from Open Orphan to hVIVO plc. Learn more on why #hVIVO made this strategic business decision. youtu.be/yUHCabwf2UA Our ticker has changed to #HVO Follow👉hVIVO to keep up to date!

Make sure you follow hVIVO for company updates…

Reminder we are holding a Capital Markets Day tomorrow at 9.30 am - 12.00 pm. 🧑Chaired by our #CEO 🔬 Insights into the business 📈 Human challenge trials & the growing market 🗣️ Guest speakers, including Peter Openshaw ❓ Q&A with management Register: stream.brrmedia.co.uk/broadcast/634f…